The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125658532 12565853 2 F 20160510 20160909 20160718 20160915 EXP FR-PFIZER INC-2016339050 PFIZER 73.00 YR F Y 0.00000 20160915 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125658532 12565853 1 PS XANAX ALPRAZOLAM 1 Oral 0.125 MG, 2X/DAY 18276 .125 MG TABLET BID
125658532 12565853 2 I OXYNORM OXYCODONE HYDROCHLORIDE 1 10 MG, 2X/DAY (ONE IN THE MORNING, ONE IN THE EVENING) Y N 0 10 MG CAPSULE BID
125658532 12565853 3 I DUROGESIC FENTANYL 1 Transdermal ONE DOSAGE FORM EACH 72 HOURS Y 0 1 DF TRANSDERMAL PATCH
125658532 12565853 4 I NORSET MIRTAZAPINE 1 Oral 30 MG (15MG X2), 1X/DAY (IN THE EVENING) 0 30 MG ORODISPERSIBLE TABLET QD
125658532 12565853 5 C INNOHEP TINZAPARIN SODIUM 1 Subcutaneous 14000 IU, DAILY 0 14000 IU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
125658532 12565853 6 C CANDESARTAN CANDESARTAN 1 Oral 4 MG, 1X/DAY (IN THE MORNING) 0 4 MG QD
125658532 12565853 7 C KARDEGIC ASPIRIN LYSINE 1 Oral 75 MG, DAILY 0 75 MG POWDER FOR ORAL SOLUTION
125658532 12565853 8 C PARACETAMOL ACETAMINOPHEN 1 1 G, 3X/DAY 0 1 G TID
125658532 12565853 9 C DUPHALAC LACTULOSE 1 10 MG, 1X/DAY (IN THE MORNING) 0 10 MG QD
125658532 12565853 10 C REVLIMID LENALIDOMIDE 1 Oral 10 MG, DAILY 0 10 MG
125658532 12565853 11 C REVLIMID LENALIDOMIDE 1 Oral 10 MG, DAILY 0 10 MG
125658532 12565853 12 C NEODEX /00016001/ DEXAMETHASONE 1 40 MG, WEEKLY 0 40 MG /wk
125658532 12565853 13 C ENDOXAN /00021101/ CYCLOPHOSPHAMIDE 1 350 MG, WEEKLY 1050 MG 0 350 MG /wk
125658532 12565853 14 C ENDOXAN /00021101/ CYCLOPHOSPHAMIDE 1 350 MG, WEEKLY 1050 MG 0 350 MG /wk
125658532 12565853 15 C AREDIA PAMIDRONATE DISODIUM 1 Intravenous (not otherwise specified) 30 MG, MONTHLY 0 30 MG /month
125658532 12565853 16 C ARANESP DARBEPOETIN ALFA 1 EVERY 21 DAYS 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125658532 12565853 1 Depression
125658532 12565853 2 Back pain
125658532 12565853 3 Back pain
125658532 12565853 4 Depression
125658532 12565853 6 Hypertension
125658532 12565853 10 Plasma cell myeloma

Outcome of event

Event ID CASEID OUTC COD
125658532 12565853 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125658532 12565853 Confusional state
125658532 12565853 Drug interaction
125658532 12565853 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125658532 12565853 2 20160510 0
125658532 12565853 3 20160510 0
125658532 12565853 10 2013 20160427 0
125658532 12565853 11 20160505 20160525 0
125658532 12565853 13 20160412 20160426 0
125658532 12565853 14 20160510 20160524 0
125658532 12565853 15 20160519 0
125658532 12565853 16 201605 0